Mankind Pharma has received a ₹183.11 crore tax demand from the Income Tax Department for AY 2014-15 to 2017-18 due to expenditure disallowances under Section 37(1). The company plans to appeal, asserting strong legal grounds. Investors are closely watching the impact on its financials and operations.
